Piramal Pharma Solutions expands its dedicated peptide active pharmaceutical ingredient (API) facility in Turbhe, India, by adding a new spray drying suite. The new addition is equipped with containment provisions described as Band 5 capacity and includes dedicated air handling units, nitrogen supply, and control systems. According to the company’s release and subsequent coverage, the suite is designed to increase the facility’s capability to support peptide formulation work. The reports say the Turbhe site is set up to run peptide-related processing in a dedicated environment, and the spray drying suite enhances those capabilities by adding additional equipment specifically for spray drying operations. Coverage across outlets focuses on the scale and components of the expansion—particularly the containment level, the dedicated utilities, and the integrated control system—rather than on financial terms or specific new customer programs. The articles present the change as a capacity and capability upgrade to Piramal Pharma Solutions’ peptide API manufacturing infrastructure in Turbhe.